| Trial ID: | L6187 |
| Source ID: | NCT01171456
|
| Associated Drug: |
Metformin
|
| Title: |
Early Intervention for Gestational Diabetes
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Gestational Diabetes Mellitus
|
| Interventions: |
DRUG: Metformin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Effect of metformin versus placebo on the development of GDM, Pre-conception to delivery (at 8 week intervals) | Secondary: Effects on maternal and fetal pregnancy outcomes of pre-conception metabolic intervention with metformin., Pre-conception until discharge from hospital after delivery (at 4 week intervals)
|
| Sponsor/Collaborators: |
Sponsor: Intermountain Health Care, Inc.
|
| Gender: |
FEMALE
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2010-04
|
| Completion Date: |
2010-07
|
| Results First Posted: |
|
| Last Update Posted: |
2013-01-16
|
| Locations: |
Intermountain Medical Center, Murray, Utah, 84107, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01171456
|
